Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector

Wael R. Abd-Elgaliel, Fabio Gallazzi, Jered C. Garrison, Tammy L. Rold, Gary L. Sieckman, Said Daibes Figueroa, Timothy J. Hoffman, Susan Z. Lever

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


The gastrin releasing peptide receptor (GRP-R) is overexpressed on a number of tumors and cancer cell lines including pancreas, prostate, breast, gastrointestinal, and small cell lung cancer (SCLC). Radiolabeled bombesin (BBN) analogues have exhibited high binding affinity and specificity to the GRP-R. A bombesin analogue with an antagonist targeting vector at the C-terminus, DOTA-aminohexanoyl-[D-Phe6, Leu-NHCH2CH2CH 313, des Met14] BBN[6-14] (1, "Bomproamide"), has been synthesized and displays high binding affinity (IC50 = 1-36 ± 0.09 nM) against 125I- Tyr4-BBN in in vitro competitive assays using PC-3 cells. Maximum internalization of 111In-1 reached 14% in PC-3 cells after 45 min of incubation. Rapid (0.25 h PI) and high (12.21 ± 3.2%ID/g) pancreatic uptake of 111In-1 was observed in healthy CF-1 mice, and 90% of the activity was blocked by coinjection of 100 μg of BBN. Rapid (0.25 h PI) and high uptake (6.90 ± 1.06%ID/g) was observed in PC-3 prostate cancer xenografts in SCID mice, as well as visualized clearly in a SPECT/CT study. These results support the use of a bombesin construct with an antagonist C-terminal vector as a candidate of choice for specific in vivo imaging of tumors overexpressing GRP-receptors.

Original languageEnglish (US)
Pages (from-to)2040-2048
Number of pages9
JournalBioconjugate Chemistry
Issue number10
StatePublished - Oct 2008
Externally publishedYes

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry


Dive into the research topics of 'Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector'. Together they form a unique fingerprint.

Cite this